Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade.
Grewal EP, Richardson LGK, Sun J, Ramapriyan R, Martinez-Lage M, Miller JJ, Cahill DP, Choi BD, Curry WT. Neurosurg Focus. 2024 Feb; 56(2):E2.